BioregulatorModerate Evidence✦ Khavinson Bioregulator

Prostatilen

Also known as: Prostate bioregulator, Samprost, Vitaprost

Khavinson prostate bioregulator that regulates prostate gene expression and function.

Evidence

Moderate

FDA status

Not FDA-approved

Source

Prostate tissue-derived peptide bioregulator

Overview

Khavinson prostate bioregulator that regulates prostate gene expression and function.

Mechanism of Action

Organ-specific bioregulator for prostate tissue, modulates gene expression in prostatic cells, reduces inflammation, supports normal prostate function and urinary flow.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Prostate health
  • Reduces prostate inflammation
  • Improves urinary flow
  • Supports normal prostate size
  • Sexual function
  • Anti-aging for prostate

Researched for

Research topics, not approved uses.

Benign prostatic hyperplasia (BPH)Chronic prostatitisUrinary dysfunctionAge-related prostate issuesPost-prostatectomy support

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. Prostatilen isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Moderate
Studies

Russian clinical trials, pharmaceutical approval

Summary

Approved in Russia (as Vitaprost and similar products) for prostate symptoms. Most studies come from Russian groups and have not been confirmed by independent trials elsewhere.

Safety Information

Potential Side Effects

  • •Few side effects reported (limited data)

Contraindications

  • Prostate cancer
  • Acute urinary retention

Interactions

  • ⚠May complement BPH medications

Quick Facts

CategoryBioregulator
SourceProstate tissue-derived peptide bioregulator
StatusApproved pharmaceutical in Russia; dietary supplement/research compound elsewhere